Greenply Industries DuPont analysis

Per cent unless marked ×
Tap a line for its trendLast 12Mto Sep 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
0.63×0.58×0.61×0.60×0.70×
0.79×0.75×0.85×0.88×0.99×
8.4%7.5%7.1%6.1%7.2%
1.40×1.40×1.38×1.30×1.30×
2.25×2.19×2.41×2.34×2.61×
13.3%10.1%12.3%9.8%16.8%
10.5%10.5%12.1%10.3%15.5%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

GREENPLY₹285.00

Greenply Industries Limited

· Consumer Goods
₹ CrorePeersSTYLAMINDGREENLAMGREENPANELRUSHILARCHIDPLYADLMcap ₹3,560 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/09/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×0.700.600.610.580.63
Interest Burden (Pretax/EBIT) ×0.990.880.850.750.79
EBIT Margin %7.196.077.147.528.42
Asset Turnover ×1.301.301.381.401.40
Financial Leverage (Assets/Equity) ×2.612.342.412.192.25
ROE (5-step product, year-end total equity) %16.829.7812.2810.0513.29
ROE (owners' profit / average owners' equity) %15.4710.3412.0810.5110.51
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.